Search Results - Qingping Feng
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19 by Brent J. Tschirhart, Brent J. Tschirhart, Xiangru Lu, Aristide Laurel Mokale Kognou, Claudio M. Martin, Claudio M. Martin, Marat Slessarev, Marat Slessarev, Douglas D. Fraser, Douglas D. Fraser, Aleksandra Leligdowicz, Aleksandra Leligdowicz, Aleksandra Leligdowicz, Bradley Urquhart, Bradley Urquhart, Qingping Feng, Qingping Feng
Published in Frontiers in Pharmacology (2024-01-01)Get full text
Article -
6
Understanding the role of Shroom3 in the developing mouse myocardium. by Jennifer L Carleton, Rami R Halabi, Jessica A Willson, Timothy F Plageman, Darren Bridgewater, Qingping Feng, Thomas A Drysda E
Published in PLoS ONE (2025-01-01)Get full text
Article -
7
-
8
Annexin A5 Inhibits Endothelial Inflammation Induced by Lipopolysaccharide-Activated Platelets and Microvesicles via Phosphatidylserine Binding by Brent J. Tschirhart, Xiangru Lu, Janice Gomes, Arundhasa Chandrabalan, Gillian Bell, David A. Hess, Guangxin Xing, Hong Ling, Dylan Burger, Qingping Feng
Published in Pharmaceuticals (2023-06-01)Get full text
Article -
9
Annexin A5 in Patients With Severe COVID-19 Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Feasibility Trial by Claudio M. Martin, MD, Marat Slessarev, MD, PhD, Eileen Campbell, John Basmaji, MD, Ian Ball, MD, Douglas D. Fraser, MD, PhD, Aleksandra Leligdowicz, MD, PhD, Tina Mele, MD, PhD, Fran Priestap, MSc, Brent J. Tschirhart, MSc, Tracey Bentall, RN, Xiangru Lu, MD, Qingping Feng, MD, PhD
Published in Critical Care Explorations (2023-10-01)Get full text
Article
